SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001070698-13-000009
Filing Date
2013-01-09
Accepted
2013-01-09 16:29:54
Documents
10
Period of Report
2012-11-30
Filing Date Changed
2013-01-09

Document Format Files

Seq Description Document Type Size
1 RAPTOR PHARMACEUTICAL CORP 10-Q_FISCAL Q1-13_11-30-2012 rptp_10q_fyq1113_113012.htm 10-Q 800176
2 CERTIFICATION OF CEO ex31_1.htm EX-31.1 8016
3 CERTIFICATION OF CFO ex31_2.htm EX-31.2 7705
4 CERTIFICATION OF CEO AND CFO ex32_1.htm EX-32.1 8326
  Complete submission text file 0001070698-13-000009.txt   4569176

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rptp-20121130.xml EX-101.INS 705161
6 XBRL TAXONOMY EXTENSION SCHEMA rptp-20121130.xsd EX-101.SCH 51939
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rptp-20121130_cal.xml EX-101.CAL 47477
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptp-20121130_lab.xml EX-101.LAB 249365
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptp-20121130_pre.xml EX-101.PRE 172012
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rptp-20121130_def.xml EX-101.DEF 65108
Mailing Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949
Business Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949 415-382-1390
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-25571 | Film No.: 13520826
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1